ArticleInvestigational new drugs2018

Acquired resistance to an epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) in an uncommon G719S EGFR mutation.

Atsushi Osoegawa et al.PubMed ↗Publisher ↗

No numbers read from the abstract.